Neuronostics

Neuronostics raised £3 million on 30 June 2026 for BioEP, its digital epilepsy biomarker, co-led by Empirical Ventures and The FSE Group with British Business Bank, blended with a £400,000 Innovate UK Investor Partnerships grant.

Spun out of the University of Exeter in 2018 by Professor John Terry and Dr Wessel Woldman, the company built BioEP to extract diagnostic features from routine EEG recordings that are invisible to standard clinical review, helping neurologists judge how likely a patient is to have epilepsy. An earlier seed round backed by the Ascension Life Fund and a syndicate including QantX and Science Angels funded the platform's initial development.

Blending equity and Innovate UK grant funding in the same round lets Neuronostics push toward UK and Middle East market access while pursuing FDA clearance in the US, at a time when EEG-reading AI tools are drawing fresh clinical and investor interest across neurology.